Stem cells in chronic myelogenous leukemia

Hematology/Oncology Clinics of North America

Volumn 11, Issue 6, 1997, Pages 1079-1114

  Verfaillie, C M ^a  

^a UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BUSULFAN; CD33 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CD71 ANTIGEN; COLLAGEN TYPE 4; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; COMPLEMENTARY DNA; CYTOKINE; CYTOKINE RECEPTOR; F ACTIN; FIBRONECTIN; FOCAL ADHESION KINASE; GROWTH FACTOR; GUANINE; HLA DR ANTIGEN; HYBRID PROTEIN; INTEGRIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; ONCOPROTEIN; PAXILLIN; PHOSPHOTYROSINE; PROTEIN TYROSINE KINASE; SERASPENIDE; THROMBOSPONDIN; THY 1 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; TYROSINE; UNINDEXED DRUG;

APOPTOSIS; BURST FORMING UNIT E; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; COLONY FORMING UNIT GM; EXTRACELLULAR MATRIX; HUMAN; IMMUNOPHENOTYPING; NONHUMAN; ONCOGENE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REVIEW; STEM CELL;

EID: 0031474526     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70484-6     Document Type: Article

References (315)

1. D.E. Afar A. Goga L. Cohen Genetic approaches to defining signaling by the CML-associated tyrosine kinase BCR-ABL Cold Spring Harb Symp Quant Biol 59 1994 589
2. D.E. Afar A. Goga J. McLaughlin Differential complementation of Bcr-Abl point mutants with c-Myc Science 264 1994 424
3. D.E. Afar J. McLaughlin C.J. Sherr Signaling by ABL oncogenes through cyclin D1 Proc Natl Acad Sci USA 92 1995 9540
4. R. Agarwal S. Doren B. Hicks C.E. Dunbar Long-term culture of chronic myelogenous leukemia marrow cells on stem cell factor–deficient stroma favors benign progenitors Blood 85 1995 1306 1312
5. A. Aitken D. Jones Y. Soneji 14-3-3 proteins: Biological function and domain structure Biochem Soc Trans 23 1995 605
6. A. Aitken K. Moelling Activated Ras displaces 14-3-3 protein from the amino terminus of c-Raf-1 Oncogene 12 1996 609
7. N.C. Allan S.M. Richards P.C. Shepherd UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: Improved survival irrespective of cytogenetic response. The UK Medical Research Council's Working Parties for Therapeutic Trials in Adult Leukaemia Lancet 345 1995 1392 1397
8. + cells that lack detectable T cell, B cell and myeloid antigens produce multiple colony forming cells when cultured with marrow stromal cells J Exp Med 172 1990 355 358
9. M.J. Barnett C.J. Eaves G.L. Phillips Autografting in chronic myeloid leukemia with cultured marrow: Update of the Vancouver Study Stem Cells 11 suppl 3 1993 64 66
10. M.J. Barnett C.J. Eaves G.L. Phillips Successful autografting in chronic myeloid leukaemia after maintenance of marrow in culture Bone Marrow Transpl 4 1989 345 351
11. C.R. Bartram deKlein A. A. Hagemeijer Translocation of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukemia Nature 306 1983 277 280
12. C.M. Baum I.L. Weissman A.S. Tsukamoto Isolation of a candidate human hematopoietic stem-cell population Proc Natl Acad Sci USA 89 1992 2804 2808
13. A. Bedi Zehnbauer B.A. Barber J.P. Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia Blood 83 1994 2038
14. A. Bedi J.P. Barber G.C. Bedi BCR-ABL–mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: A mechanism of resistance to multiple anticancer agents Blood 86 1995 1148 1155
15. A. Bedi C.A. Griffin J.P. Barber Growth factor–mediated terminal differentiation of chronic myeloid leukemia Cancer Res 54 1994 5535 5538
16. Y. Ben-Neriah G.Q. Daley A.M. Mes-Masson The chronic myelogenous leukemia–specific P210 protein is the product of the bcr/abl hybrid gene Science 233 1986 212 215
17. A.C. Berardi A. Wang J.D. Levine Functional isolation and characterization of human hematopoietic stem cells Science 267 1995 104 108
18. R.J. Berenson W.I. Bensinger R.S. Hill Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma Blood 77 1991 1717 1722
19. R. Bhatia G. Dewald P. McGlave C.M. Verfaillie Abnormalities of the bone marrow microenvironment in chronic myelogenous leukemia are related to malignant macrophages Blood 85 1995 3636 3645
20. R. Bhatia J.B. McCarthy C.M. Verfaillie Interferon-α restores normal β1-integrin mediated negative regulation of chronic myelogenous leukemia progenitor proliferation Blood 87 suppl 1 1996 3883 3891
21. R. Bhatia P.B. McGlave C.M. Verfaillie Interferon-α treatment of normal bone marrow stroma results in enhanced adhesion of CML hematopoietic progenitors via mechanisms involving MIP-1α J Clin Invest 96 1995 931 939
22. R. Bhatia H. Munthe C.M. Verfaillie Decreased β1-integrin receptor capping in CML progenitors reflecting abnormal receptor cytoskeletal interactions is normalized by interferon-α Blood 88 suppl 1 1996 2537a
23. R. Bhatia C.M. Verfaillie Inhibition of BCR-ABL expression by anti-sense oligonucleotides normalizes β1-integrin mediated adhesion and regulation of proliferation in chronic myelogenous leukemia Blood 86 suppl 1 1995 1740a
24. R. Bhatia C.M. Verfaillie Inhibition of BCR-ABL tyrosine kinase activity with tyrphostin AG975 restores β1-integrin mediated regulation of hematopoietic progenitor proliferation in CML Blood 88 suppl 1 1996 2687a
25. R. Bhatia C.M. Verfaillie Inhibition of BCR/ABL expression by anti-sense oligonucleotides normalizes β1-integrin mediated adhesion and regulation of proliferation in chronic myelogenous leukemia Blood 86 suppl 1 1995 1740a
26. R. Bhatia E. Wayner P. McGlave C.M. Verfaillie Interferon-α restores adhesion of malignant progenitors in CML by restoring β1 integrin function J Clin Invest 94 1994 384 391
27. S.A. Bonanou-Tzedaki M. Sohi H.R. Arnstein Regulation of erythroid cell differentiation by haemin Cell Differ 10 1981 267 279
28. D. Bonnet R. Cesaire F. Lemoine The tetrapeptide AcSDKP, an inhibitor of the cell-cycle status for normal human hematopoietic progenitors, has no effect on leukemic cells Exp Hematol 20 1992 251 255
29. D. Bonnet F.M. Lemoine S. Pontvert-Delucq Direct and reversible inhibitory effect of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (Seraspenide) on the growth of human CD34+ subpopulations in response to growth factors Blood 82 1993 3307 3314
30. C. Bovolenta P.H. Driggers M.S. Marks Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family Proc Natl Acad Sci USA 91 1994 5046 5050
31. J. Brandt N. Baird L. Lu Characterization of a human hematopoietic progenitor cell capable of forming blast cell containing colonies in vitro J Clin Invest 82 1988 1017 1027
32. J.M. Brandwein I.D. Dube P. Laraya A. Keating Maintenance of Philadelphia-chromosome–positive progenitors in long-term marrow cultures from patients with advanced chronic myeloid leukemia Leukemia 6 1992 556 561
33. M.K. Brenner D.R. Rill R.C. Moen Gene-marking to trace origin of relapse after autologous transplantation Lancet 341 1993 85 89
34. J. Briscoe D. Guschin N.C. Rogers JAKs, STATs and signal transduction in response to the interferons and other cytokines Philosophical Transactions of the Royal Society of London—Series B: Biological Sciences 351 1996 167 171
35. T.M. Browder J.S. Abrams P.M. Wong A.W. Nienhuis Mechanism of autocrine stimulation in hematopoietic cells producing interleukin-3 after retrovirus-mediated gene transfer Mol Cell Biol 9 1989 204 213
36. H.E. Broxmeyer L. Benninger N. Hague Suppressive effects of the chemokine family of cytokines on proliferation of normal and leukemic myeloid cell proliferation Guigon M. The Negative Regulation of Hematopoiesis, vol 229. Colloque INSERM 1993 John Libbey Eurotext London 141
37. H.E. Broxmeyer B. Sherry S. Cooper Macrophage inflammatory protein (MIP)-1 beta abrogates the capacity of MIP-1 alpha to suppress myeloid progenitor cell growth J Immunol 147 1991 2586 2594
38. H.E. Broxmeyer B. Sherry L. Lu Enhancing and suppressing effects of recombinant murine macrophage inflammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cells Blood 76 1990 1110 1116
39. A. Butturini R.P. Gale The role of T-cells in preventing relapse in chronic myelogenous leukemia Bone Marrow Transpl 2 1987 351 354
40. G.P. Canellos Clinical characteristics of the blast phase of chronic myelogenous leukemia Hematol Oncol Clin North Am 4 1990 359
41. N. Caprino D. Wisniewski A. Strife p62dok: A constitutively tyrosine-phosphorylated GAP-associated protein in chronic myelogenous leukemia Cell 88 1997 197 204
42. A.M. Carella M. Podesta F. Grassoni Selective overshoot of Ph-negative blood hemopoietic cells after an intensive idarubicin-containing regimen and their repopulating capacity after reinfusion Journal of Hematotherapy 3 1994 199 202
43. N. Carlesso D.A. Frank J.D. Griffin Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl J Exp Med 183 1996 811
44. N. Carlesso J.D. Griffin B.J. Druker Use of a temperature sensitive mutant to define biological effects of the p210BCR-ABL tyrosine kinase on proliferation of a factor dependent murine cell line Oncogene 9 1994 149
45. C.E. Carow M. Levenstein S.H. Kaufmann Expression of the hematopoietic growth factor receptor FLT3 (STK-1/Flk2) in human leukemias Blood 82 1996 1089 1096
46. J.D. Cashman A.C. Eaves C.J. Eaves Granulocyte-macrophage colony-stimulating factor modulation of the inhibitory effect of transforming growth factor-beta on normal and leukemic human hematopoietic progenitor cells Leukemia 6 1992 886 892
47. J.D. Cashman A.C. Eaves C.J. Eaves The tetrapeptide AcSDKP specifically blocks the cycling of primitive normal but not leukemic progenitors in long-term culture: Evidence for an indirect mechanism Blood 84 1994 1534 1542
48. J.D. Cashman A.C. Eaves E.W. Raines Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-beta Blood 75 1990 96 101
49. J.D. Cashman A.C. Eaves S. Wolpe C.J. Eaves Regulatory activity of endogenous MIP-1 alpha in long-term cultures of human marrow Prog Clin Biol Res 389 1994 261 168
50. H. Castro-Malaspina R.E. Gay S.C. Jhanwar Characteristics of bone marrow fibroblast colony-forming cells [CFU-F] and their progeny in patients with myeloproliferative disorders Blood 59 1982 1046 1054
51. H. Castro-Malaspina Laver J. S. Jhanwar Studies on the microenvironment in human chronic myelogenous leukemia Exp Hematol 12 1984 470 478
52. R.A. Cerione Y. Zheng The Dbl family of oncogenes Curr Opin Cell Biol 8 1996 216
53. R.C. Chasty G.S. Lucas P.J. Owen-Lynch Macrophage inflammatory protein-1 alpha receptors are present on cells enriched for CD34 expression from patients with chronic myeloid leukemia Blood 86 1995 4270 4277
54. H.C. Chen J.L. Guan Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase Proc Natl Acad Sci USA 91 1994 10148
55. E.A. Clark J.S. Brugge Integrins and signal transduction pathways: The road taken Science 268 1995 233
56. I. Clark-Lewis K.S. Kim K. Rajarathnam Structure-activity relationships of chemokines J Leukoc Biol 57 1995 703 711
57. B. Clarkson A. Strife Linkage of proliferative and maturational abnormalities in chronic myelogenous leukemia and relevance to treatment Leukemia 7 1993 1683
58. J.E. Cortes M. Talpaz H. Kantarjian Chronic myelogenous leukemia: A review Am J Med 100 1996 555 570
59. D. Cortez L. Kadlec A.M. Pendergast Structural and signaling requirements for BCR-ABL–mediated transformation and inhibition of apoptosis Mol Cell Biol 15 1995 5531
60. T.G. Cotter BCR-ABL: An anti-apoptosis gene in chronic myelogenous leukemia Leuk Lymphoma 1 1995 231
61. L. Coulombel D.K. Kalousek C.J. Eaves Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome–positive chronic myelogenous leukemia N Engl J Med 308 1983 1493 1498
62. S.W. Craig R.P. Johnson Assembly of focal adhesions: Progress, paradigms, and portents Curr Opin Cell Biol 8 1996 74 85
63. W. Craig R. Kay R.L. Cutler P.M. Lansdorp Expression of Thy-1 on human hematopoietic progenitor cells J Exp Med 177 1993 1331 1342
64. G.Q. Daley D. Baltimore Transformation of an interleukin 3–dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein Proc Natl Acad Sci USA 85 1988 9312
65. G.Q. Daley Van Etten R.A. D. Baltimore Blast crisis in a murine model of chronic myelogenous leukemia Proc Natl Acad Sci USA 88 1991 11335
66. BCR-ABL gene of the Philadelphia chromosome Science 247 1990 824 829
67. G.Q. Daley Van Etten R.A. P.K. Jackson Nonmyristoylated Abl proteins transform a factor-dependent hematopoietic cell line Mol Cell Biol 12 1992 1864 1831
68. N.N. Danial A. Pernis P.B. Rothman Jak-STAT signaling induced by the v-abl oncogene Science 269 1995 1875 1878
69. J. Decker W. Fiedler A. Samalecos D.K. Hossfeld Absence of point mutations in the extracellular domain of the alpha subunit of the GM-CSF receptor in a series of patients with acute myeloid leukemia (AML) Leukemia 9 1995 185 188
70. R. de Jong ten Hoeve J. N. Heisterkamp Crkl is complexed with tyrosine-phosphorylated Cbl in Ph-positive leukemia J Biol Chem 270 1995 21468
71. A.B. Deisseroth Z. Zhifei D. Claxton Genetic marking shows that Ph+ cells present in autologous marrow of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow transplants in CML Blood 83 1994 3068 3076
72. M. Delforge M.A. Boogaerts P.B. McGlave C.M. Verfaillie CD34+HLA-DR- cells in chronic phase CML, but not in more advanced phase CML, are polyclonal Blood 88 suppl 1 1996 907a
73. H.M. DeLisser P.J. Newman S.M. Albelda Molecular and functional aspects of PECAM-1/CD31 Immunology Today 15 1994 490 495
74. M.W. Dercksen W.R. Gerritsen S. Rodenhuis Expression of adhesion molecules on CD34+ cells: CD34+ L-selectin+ cells predicts a rapid platelet recovery after peripheral blood stem cell transplantation Blood 85 1995 3313
75. D. Despres J. Goldschmitt W.E. Aulitzky Differential effect of type I interferons on hematopoietic progenitor cells: Failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors Exp Hematol 23 1995 1431 1438
76. T.M. Dexter Granulocyte colony stimulating factor: From laboratory bench to clinical use Eur J Cancer 30A suppl 3 1994 S15 S19
77. S. Dhut T. Chaplin B.D. Young BCR-ABL and BCR proteins: Biochemical characterization and localization Leukemia 4 1990 745
78. J. Diamond J.M. Goldman J.V. Melo BCR-ABL, ABL-BCR, BCR, and ABL genes are all expressed in individual granulocyte-macrophage colony-forming unit colonies derived from blood of patients with chronic myeloid leukemia Blood 85 1995 2171 2175
79. D. Diekmann S. Brill M.D. Garrett Bcr encodes a GTPase-activating protein for p21rac Nature 351 1991 400 402
80. D. DiGiusto S. Chen J. Combs Human fetal bone marrow early progenitors for T, B, and myeloid cells are found exclusively in the population expressing high levels of CD34 Blood 84 1994 421 432
81. G.J. Dougherty P.M. Lansdorp D.L. Cooper R.K. Humphries Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte “homing” receptor expressed by hemopoietic cells J Exp Med 174 1991 1 5
82. C. Dowding M. Gordon A.P. Guo Potential mechanisms of action of interferon-alpha in CML Leuk Lymphoma 11 suppl 1 1993 185 191
83. C. Dowding A.P. Guo J. Osterholz Interferon-alpha overrides the deficient adhesion of chronic myeloid leukemia primitive progenitor cells to bone marrow stromal cells Blood 78 1991 499
84. C.R. Dowding M.Y. Gordon J.M. Goldman Increased DR antigen expression by committed hemopoietic progenitor cells but not primitive progenitor cells in chronic myeloid leukemia Exp Hematol 16 1988 171 175
85. H.G. Drexler Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells Leukemia 10 1996 588 599
86. B.J. Druker S. Tamara E. Buchdunger Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells Nature Medicine 2 1996 561
87. X.X. Du D.A. Williams Interleukin-11, a multifunctional growth factor derived from the hematopoietic microenvironment Blood 83 1994 2023 2030
88. I.D. Dube D.K. Kalousek L. Coulombel Cytogenetic studies of early myeloid progenitor compartments in Ph1-positive chronic myeloid leukemia. II. Long-term culture reveals the persistence of Ph1-negative progenitors in treated as well as newly diagnosed patients Blood 63 1984 1172 1177
89. D.J. Dunlop E.G. Wright S. Lorimore Demonstration of stem cell inhibition and myeloprotective effects of SCI/rhMIP1 alpha in vivo Blood 79 1992 2221 2225
90. A.C. Eaves J.D. Cashman L.A. Gaboury Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells Proc Natl Acad Sci USA 83 1986 5306 5310
91. A.C. Eaves C.J. Eaves Abnormalities in the erythroid compartment in patients with chronic myeloid leukemia Exp Haematol 7 1977 65 75
92. C.J. Eaves J.D. Cashman R.J. Kay Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer Blood 78 1991 110 117
93. C.J. Eaves J.D. Cashman S.D. Wolpe A.C. Eaves Unresponsiveness of primitive chronic mycloid leukemia cells to macrophage inflammatory protein 1 alpha, an inhibitor of primitive normal hematopoietic cells Proc Natl Acad Sci USA 90 1993 12015 12019
94. F. Eberle Y. Toiron J. Camerlo Persistence of BCR/ABL mRNA-expressing bone-marrow cells in patients with chronic myelogenous leukemia in complete cytogenetic remission induced by interferon-alpha therapy Leuk Lymph 18 1995 153 157
95. R.S. Fernandes A.M. Gorman A. McGahon The repression of apoptosis by activated abl oncogenes in chronic myelogenous leukaemia Leukemia 10 suppl 2 1996 s17
96. P.J. Fialkow R.J. Jacobson T.H. Papayannopoulou Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage Am J Med 63 1977 125 130
97. E. Filvaroff E. Calautti F. McCormick G.P. Dotto Specific changes of Ras GTPase-activating protein (GAP) and a GAP-associated p62 protein during calcium-induced keratinocyte differentiation Mol Cell Biol 12 1992 5319 5328
98. C.C. Fraser H. Kaneshima G. Hansteen Human allogeneic stem cell maintenance and differentiation in a long-term multilineage SCID-hu graft Blood 86 1995 1680 1693
99. E. Frindel M. Guigon Inhibition of CFU entry into cycle by a bone marrow extract Exp Hematol 5 1977 74 76
100. S. Ghaffari G. Dougherty C.J. Eaves Positive and negative effects of different epitope-specific anti-CD44 antibodies on stromal cell-dependent hematopoiesis Blood 87 1995 1217a
101. S. Ghaffari G.J. Dougherty P.M. Lansdorp Differentiation-associated changes in CD44 isoform expression during normal hematopoiesis and their alteration in chronic myeloid leukemia Blood 86 1995 2976 2985
102. M.L. Gishizky J. Johnson-White O.N. Witte Efficient transplantation of BCR-ABL–induced chronic myelogenous leukemia-like syndrome in mice Proc Natl Acad Sci USA 90 1993 3755
103. M.L. Gishizky O.N. Witte Initiation of dysregulated growth of multipotent progenitor cells by bcr-abl in vitro Science 256 1992 836
104. A. Goga J. McLaughlin D.E. Afar Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene Cell 82 1995 981
105. J.M. Goldman F. Shiota K.H. Th'ng K.H. Orchard Circulating granulocytic and erythroid progenitor cells in chronic granulocytic leukemia Br J Haematol 46 1980 7 13
106. M.Y. Gordon C.R. Dowding G.P. Riley Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia Nature 328 1987 342 344
107. M.Y. Gordon J.L. Lewis M.A. Scott Probability of progenitor renewal (PPR) and production of clonogenic progeny (CFU-GM) by primitive adherent progenitor cells in adult human one marrow and umbilical cord blood Br J Haematol 90 1995 744 749
108. M.Y. Gordon G.P. Riley D. Clarke Heparan sulfate is necessary for adhesive interactions between human early hemopoietic progenitor cells and the extracellular matrix of the marrow microenvironment Leukemia 2 1988 804 809
109. M.Y. Gordon Cell biology of CML—a model linking the chronic and terminal phases Leuk Lymphoma 11 suppl 1 1993 93 100
110. S.D. Gore S. Amin L.J. Weng C.I. Civin Steel factor supports the cycling of isolated human CD34+ cells in the absence of other growth factors Exp Hematol 23 1995 413 421
111. H.M. Goselink D.E. Williams W.E. Fibbe Effect of mast cell growth factor (c-kit ligand) on clonogenic leukemic precursor cells Blood 80 1992 750 757
112. T. Goto M. Nishikori Z. Arlin Growth characteristics of leukemic and normal hematopoietic cells in Ph1 + chronic myelogenous leukemia and effects of intensive treatment Blood 59 1982 793 808
113. A. Gotoh K. Miyazawa K. Ohyashiki Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein Exp Hematol 23 1995 1153
114. G.J. Graham E.G. Wright R. Hewick Identification and characterization of an inhibitor of haemopoietic stem cell proliferation Nature 344 1990 442 444
115. B.R. Greenberg F.D. Wilson L. Woo H.M. Jenks Cytogenetics of fibroblastic colonies in Ph1-positive chronic myelogenous leukemia Blood 51 1978 1039 1044
116. J.S. Greenberger Is the marrow stroma of AML patients a “leukemic” stroma? Exp Hematol 20 1992 1041 1042
117. M. Guigon D. Bonnet R. Cesaire Effects of small peptidic inhibitors of murine stem cells on human normal and malignant cells Ann NY Acad Sci 628 1991 105 114
118. M. Hallek S. Danhauser-Riedl R. Herbst Interaction of the receptor tyrosine kinase p145c-kit with the p210bcr/abl kinase in myeloid cells Br J Haematol 94 1996 5 16
119. D. Harrison-Findik M. Susa L. Varticovski Association of phosphatidylinositol 3-kinase with SHC in chronic myelogeneous leukemia cells Oncogene 10 1995 1385
120. R. Hehlmann H. Heimpel J. Hasford Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group Blood 84 1994 4064 4077
121. J.A. Hickman Apoptosis and chemotherapy resistance Eur J Cancer 32A 1996 921
122. J. Hirata H. Takahira S. Kaneko Bone marrow stromal cells in myeloproliferative disorders Acta Haematol 82 1989 35 39
123. E. Hirsch A. Iglesias A.J. Potocnik Impaired migration but not differentiation of haematopoietic stem cells in the absence of β1 integrins Nature 380 1996 171
124. B. Hoffman D.A. Liebermann M. Selvakumaran Role of c-myc in myeloid differentiation, growth arrest and apoptosis Curr Topics Microbiol Immunol 211 1996 17
125. R. Hoffman J. Tong J. Brandt The in vitro and in vivo effects of stem cell factor on human hematopoiesis Stem Cells 11 suppl 2 1993 76 82
126. T. Holtschke J. Lohler Y. Kanno Immunodeficiency and chronic myelogenous leukemia–like syndrome in mice with a targeted mutation of the ICSBP gene Cell 87 1996 307 317
127. T.L. Holyoake M.G. Freshney A.M. Sproul Contrasting effects of rh-MIP-1 alpha and TGF-beta on chronic myeloid leukemia progenitors in vitro Stem Cells 11 suppl 3 1993 122 128
128. R. Horuk Molecular properties of the chemokine receptor family Trends Pharmacol Sci 15 1994 159 165
129. R Hurley, JB McCarthy, CM Verfaillie, Clustering of integrins results in proliferation inhibition of committed hematopoietic progenitors through mechanisms involving the cell cytoskeleton. Exp Hematol, in press
130. R.W. Hurley J.B. McCarthy C.M. Verfaillie Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation J Clin Invest 96 1995 511 519
131. J.N. Ihle B.A. Witthuhn F.W. Quelle Signaling through the hematopoietic cytokine receptors Annu Rev Immunol 13 1995 369
132. C. Issaad W. Vainchenker Growth of erythroid colonies in chronic myelogenous leukemia is independent of erythropoietin only in the presence of steel factor Blood 84 1994 3447 3456
133. Italian Cooperative Study Group on Chronic Myeloid Leukemia Chronic myeloid leukemia, BCR/ABL transcript, response to alpha-interferon and survival Leukemia. 9 1995 1648 1652
134. B. Jazwiec F.X. Mahon A. Pigneux 5-Fluorouracil-resistant CD34+ cell population from peripheral blood of CML patients contains BCR-ABL-negative progenitor cells Exp Hematol 23 1995 1509 1514
135. B.M. Jockusch P.B.K. Giehl M. Kroemker The molecular architecture of focal adhesions Annu Rev Cell Dev Biol 11 1995 379
136. R.J. Jones J.E. Wagner P. Celano Separation of pluripotent hematopoietic stem cells from spleen colony-forming cells Nature 347 1990 188 190
137. G.S. Kansas Selectins and their ligands: Current concepts and controversies Blood 88 1996 3259 3287
138. H.M. Kantarjian T.L. Smith K.B. McCredie Chronic myelogenous leukemia: A multivariate analysis of the associations of patient characteristics and therapy with survival Blood 66 1985 1326
139. K. Kawaishi A. Kimura O. Katoh Decreased L-selectin expression in CD34-positive cells from patients with chronic myelocytic leukaemia Br J Haematol 93 1996 367 374
140. A. Keating B.A. Guinn P. Laraya X.H. Wang α-interferon downregulates transcription of BCR-ABL in colonies arising from Ph+ early hematopoietic progenitors in patients with chronic myeloid leukemia Blood 86 suppl 1 1995 2096a
141. J.R. Keller S.H. Bartelmez E. Sitnicka Distinct and overlapping direct effects of macrophage inflammatory protein-1 alpha and transforming growth factor beta on hematopoietic progenitor/stem cell growth Blood 84 1994 2175 2181
142. J.R. Keller I.K. McNiece K.T. Sill Transforming growth factor β directly regulates primitive murine hematopoeitic cell proliferation Blood 75 1990 596 602
143. J.M. Kerst J.B. Sanders I.C. Slaper-Cortenbach Alpha 4 beta 1 and alpha 5 beta 1 are differentially expressed during myelopoiesis and mediate the adherence of human CD34+ cells to fibronectin in an activation-dependent way Blood 81 1993 344 351
144. J.A. Kirk J.A. Reems B.A. Roecklein Benign marrow progenitors are enriched in the CD34+/HLA-DRlo population but not in the CD34+/CD381o population in chronic myeloid leukemia: An analysis using interphase fluorescence in situ hybridization Blood 86 1995 737 743
145. N.L. Kovach T.M. Carlos E. Yee J.M. Harlan A monoclonal antibody to β1 integrin [CD29] stimulates VLA-dependent adherence of leukocytes to human umbilical vein endothelial cells and matrix components J Cell Biol 116 1992 499 509
146. F. Kuto T. Nagaoka Y. Watanabe Chronic myelocytic leukemia: Ultrastructural histopathology of bone marrow from patients in the chronic phase Ultrastruct Pathol 6 1984 307 317
147. P. Laneuville Abl tyrosine protein kinase Semin Immunol 7 1995 255
148. P.M. Lansdorp W. Dragowska H. Mayani Ontogeny-related changes in proliferative potential of human hematopoietic cells J Exp Med 178 1993 787
149. P.M. Lansdorp W. Dragowska Long-term erythropoiesis from constant numbers of CD34+ cells in serum-free cultures initiated with highly purified progenitor cells from human bone marrow J Exp Med 175 1992 1501 1509
150. T. Lapidot F. Pflumio M. Doedens Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice Science 255 1992 1137 1141
151. D.I. Leavesley J.M. Oliver B.W. Swart Signals from platelet/endothelial cell adhesion molecule enhance the adhesive activity of the very late antigen-4 integrin of human CD34+ hemopoietic progenitor cells J Immunol 153 1994 4673 4683
152. T. Leemhuis D. Leibowitz G. Cox Identification of BCR/ABL-negative primitive hematopoietic progenitor cells within chronic myeloid leukemia marrow Blood 81 1993 801 807
153. M. Lenfant J. Wdzieczak-Bakala E. Guittet Inhibitor of hematopoietic pluripotent stem cell proliferation: Purification and determination of its structure Proc Natl Acad Sci USA 86 1989 779 782
154. J. Lesley Q. He K. Miyake Requirement for hyaluronic acid binding by CD44: A role for the cytoplasmic domain and activation by antibody J Exp Med 175 1992 257 266
155. J.L. Liesveld J.M. Winslow K.E. Frediani Expression of integrins and examination of their adhesive function in normal and leukemic hematopoietic cells Blood 81 1993 112 121
156. A. Lindemann R. Mertelsmann Interleukin-3: Structure and function Cancer Invest 11 1993 609 623
157. T. Lion Clinical implications of qualitative and quantitative polymerase chain reaction analysis in the monitoring of patients with chronic myelogenous leukemia. The European Investigators on Chronic Myeloid Leukemia Group Bone Marrow Transplant 14 1994 505 509
158. M.W. Long V.M. Dixit Thrombospondin functions as a cytoadhesion molecule for human hematopoietic progenitor cells Blood 75 1990 2311 2318
159. B.I. Lord C.M. Heyworth L.B. Woolford Macrophage inflammatory protein: Its characteristics, biological properties and role in the regulation of haemopoiesis Int J Hematol 57 1993 197
160. BI Lundell, JB McCarthy, NL Kovach, CM Verfaillie, Activation of β1-integrins on CML progenitors reveals cooperation between β1-integrins and CD44 in regulation of adhesion and proliferation. Leukemia, in press
161. B.I. Lundell J.B. McCarthy N.L. Kovach C.M. Verfaillie Adhesion to fibronectin (FN) induced by the activating anti-integrin-β1 antibody, 8a2, restores adhesion mediated inhibition of CML progenitor proliferation Blood 87 1996 2450 2458
162. J. Maciejewski C. Selleri S. Anderson N.S. Young Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro Blood 85 1995 3183 3190
163. V. Maguer-Satta A.L. Petzer A.C. Eaves C.J. Eaves BCR-ABL expression in different subpopulations of functionally characterized Ph+ CD34+ cells from patients with chronic myeloid leukemia Blood 88 1996 1796 1804
164. S.B. Marley T.A. Amos M.Y. Gordon Kinetics of colony formation by BFU-E grown under different culture conditions in vitro Br J Haematol 92 1996 559 561
165. S.B. Marley J.L. Lewis J.M. Goldman M.Y. Gordon Abnormal kinetics of colony formation by erythroid burst-forming units (BFU-E) in chronic myeloid leukaemia Br J Haematol 93 1996 878 883
166. Y. Maru O.N. Witte The BCR gene encodes a novel serine/threonine kinase activity within a single exon Cell 67 1991 459
167. J.M. McCune R. Namikawa H. Kaneshima The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function Science 241 1988 1632 1639
168. A. McGahon R. Bissonnette M. Schmitt BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death Blood 83 1994 1179
169. P. McGlave S. Mamus B. Vilen G. Dewald Effect of recombinant gamma interferon on chronic myelogenous leukemia bone marrow progenitors Exp Hematol 15 1987 331 335
170. P. McGlave Bone marrow transplants in chronic myelogenous leukemia: An overview of determinants of survival Semin Hematol 27 1990 23 30
171. P. McGlave Unrelated donor and autologous marrow transplant therapy of chronic myelogenous leukemia Leukemia 7 1993 1092 1083
172. P.B. McGlave D. Arthur W.J. Miller Autologous transplantation for CML using marrow treated ex vivo with recombinant human interferon gamma Bone Marrow Transplant 6 1990 115 120
173. P.B. McGlave P. DeFabritiis A. Deisseroth Autologous transplant therapy for chronic myelogenous leukemia prolongs survival: Results from eight transplant centers Lancet 343 1994 1486 1488
174. I.K. McNiece I. Bertoncello A.B. Kriegler P.J. Quesenberry Colony-forming cells with high proliferative potential (HPP-CFC) Int J Cell Cloning 8 1990 146 160
175. J.R. McWhirter D.L. Galasso J.Y. Wang A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins Mol Cell Biol 13 1993 7587
176. J.R. McWhirter J.Y. Wang Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins Mol Cell Biol 11 1991 1553
177. J.R. McWhirter J.Y. Wang An actin-binding function contributes to transformation by the BCR-ABL oncoprotein in Philadelphia chromosome positive human leukemias EMBO J 12 1993 1533 1546
178. J.V. Melo D.E. Gordon N.C. Cross The ABL-BCR fusion gene is expressed in chronic myeloid leukemia Blood 81 1993 158
179. J.V. Melo The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype Blood 88 1996 2375
180. C. Minshall S. Arkins G.G. Freund Requirement for phosphatidylinositol 3′-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor J Immunol 156 1996 939
181. K. Miyake K.L. Medina Hayashi S.-I. Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures J Exp Med 171 1990 477 488
182. S. Miyamoto H. Teramoto O.A. Coso Integrin function: Molecular hierarchies of cytoskeletal and signaling molecules J Cell Bio 1995 791 805
183. R. Mohle S. Murea M. Kirsch R. Haas Differential expression of L-selectin, VLA-4, and LFA-1 on CD34+ progenitor cells from bone marrow and peripheral blood during G-CSF–enhanced recovery Exp Hematol 23 1995 1535
184. T. Mughal C. Hoyle J.M. Goldman Autografting for patients with chronic myeloid leukemia—the Hammersmith experience Stem Cells 11 suppl 3 1993 20 22
185. A.J. Muller J.C. Young A.M. Pendergast BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene in Philadelphia chromosome positive leukemias Mol Cell Biol 11 1991 1785
186. I. Murohashi K. Endho S. Nishida Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation Exp Hematol 23 1995 970 977
187. K. Muroi M. Nakamura Y. Amemiya Expression of c-kit receptor (CD117) and CD34 in leukemic cells Leuk Lymphoma 16 1995 297 305
188. S. Nakanishi H. Yano Y. Matsuda Novel functions of phosphatidylinositol 3-kinase in terminally differentiated cells Cell Signaling 7 1995 545 557
189. K. Nakase K. Kita A. Otsuji Diagnostic and clinical importance of interleukin-2 receptor alpha chain expression on non-T-cell acute leukaemia cells Br J Haematol 80 1992 317 326
190. Y. Nakata A. Kimura O. Katoh c-kit point mutation of extracellular domain in patients with myeloproliferative disorders Br J Haematol 91 1995 661 663
191. N. Nelson Y. Kanno C. Hong Expression of IFN regulatory factor family proteins in lymphocytes. Induction of Stat-1 and IFN consensus sequence binding protein expression by T cell activation J Immunol 156 1996 3711 3720
192. N. Nelson M.S. Marks P.H. Driggers K. Ozato Interferon consensus sequence-binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription Mol Cell Biol 13 1993 588 599
193. N.L. Nicolson M. Talpaz G.L. Nicolson Interferon-alpha directly inhibits DNA polymerase activity in isolated chromatin nucleoprotein complexes: Correlation with IFN-alpha treatment outcome in patients with chronic myelogenous leukemia Gene 159 1995 105 111
194. N. Nirsimloo M.Y. Gordon Progenitor cells in the blood and marrow of patients with chronic phase chronic myeloid leukaemia respond differently to macrophage inflammatory protein-1 alpha Leuk Res 19 1995 319 323
195. J.A. Nolta M.B. Hanley D.B. Kohn Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: Analysis of gene transduction of long-lived progenitors Blood 83 1994 3041 3051
196. P.C. Nowell D.A. Hungerford A minute chromosome in human chronic granulocytic leukemia Science 132 1960 1497
197. S. O'Brien H. Kantarjian M. Shtalrid Lack of breakpoint cluster region rearrangement in marrow fibroblasts of patients with Philadelphia chromosome–positive chronic myelogenous leukemia Hematol Pathol 2 1988 25 29
198. T. Oda C. Heaney J.R. Hagopian Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia J Biol Chem 269 1994 22925
199. R.A. Oostendorp E. Spitzer P. Dormer Adhesion of human hematopoietic progenitor cells to bone-marrow–derived stromal cells is enhanced by antibodies to CD44 Acta Haematol 95 1996 243 247
200. T. Otsuka C.J. Eaves R.K. Humphries Lack of evidence for abnormal autocrine or paracrine mechanisms underlying the uncontrolled proliferation of primitive chronic myeloid leukemia progenitor cells Leukemia 5 1991 861 868
201. A.F. Overbeck T.R. Brtva A.D. Cox Guanine nucleotide exchange factors: Activators of Ras superfamily proteins Mol Reprod Dev 42 1995 468
202. T. Papayannopoulou C. Craddock B. Nakamoto The VLA4/VCAM adhesion pathway defines contrasting mechanisms of lodging of transplanted murine hematopoietic progenitors between bone marrow and spleen Proc Natl Acad Sci USA 92 1995 9647 9651
203. T. Papayannopoulou B. Nakamato Systemic treatment of primates with anti-VLA4 leads to an immediate egress of hemopoietic progenitors to periphery Proc Natl Acad Sci USA 90 1993 9374 9378
204. V.P. Patel H.F. Lodish Erythroleukemia cells into reticulocytes J Cell Biol 105 1987 3105 3118
205. W.R. Paukovits M. Guigon K.A. Binder Prevention of hematotoxic side effects of cytostatic drugs in mice by a synthetic hemoregulatory peptide Cancer Res 50 1990 328 332
206. A.M. Pendergast M.L. Gishizky M.H. Havlik O.N. Witte SH1 domain autophosphorylation of p210 BCR-ABL is required for transformation but not growth factor independence Mol Cell Biol 13 1993 1728 1732
207. A.M. Pendergast L.A. Quilliam L.D. Cripe BCR-ABL–induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein Cell 75 1993 175 185
208. A.M. Pendergast A.J. Muller M.H. Havlik BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner Cell 66 1991 161 171
209. A.L. Petzer C.J. Eaves P.M. Lansdorp Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia Blood 88 1996 2162 2171
210. G.E. Plopper H.P. McNamee L.E. Dike Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex Mol Biol Cell 6 1995 1349 1365
211. F. Prosper D. Stronceck C.M. Verfaillie Phenotypic and functional characterization of long-term culture initiating cells (LTC-IC) present in peripheral blood progenitor collections of normal donors treated with G-CSF Blood 88 1996 2033 2042
212. F. Prosper D. Stroncek C.M. Verfaillie Expansion of primitive LTC-IC from G-CSF mobilized peripheral blood progenitor cells (PBPC) Blood 89 1997 3991 3997
213. V.F. Quesniaux G.J. Graham I. Pragnell Use of 5-fluorouracil to analyze the effect of macrophage inflammatory protein-1 alpha on long-term reconstituting stem cells in vivo Blood 81 1993 1497 1504
214. C.J. Raport V.L. Schweickart D. Chantry New members of the chemokine receptor gene family J Leukoc Biol 59 1996 18 23
215. J.C. Reed Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance Curr Opin Oncol 7 1995 541
216. J. Reiffers J. Goldman G. Meloni Autologous stem cell transplantation in chronic myelogenous leukemia: A retrospective analysis of the European Group for Bone Marrow Transplantation. Chronic Leukemia Working Party of the EBMT Bone Marrow Transplant 14 1994 407
217. M.W. Renshaw J.R. McWhirter J.Y. Wang The human leukemia oncogene bcr-abl abrogates the anchorage requirement but not the growth factor requirement for proliferation Mol Cell Biol 15 1995 1286 1293
218. G.W. Reuther H. Fu L.D. Cripe Association of the protein kinases c-Bcr and Bcr-Abl with proteins of the 14-3-3 family Science. 266 1994 129
219. D.R. Rill M. Santana M. Roberts Direct demonstration that autologous marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells Blood 84 1994 380 383
220. M.J. Robertson D.C. Roy R.M. Stone J. Ritz Use of CD33 monoclonal antibodies in bone marrow transplantation for acute myeloid leukemia Prog Clin Biol Res 389 1994 47 63
221. C. Rosales V. O'Brien L. Kornberg R. Juliano Signal transduction by cell adhesion receptors Biochim Biophys Acta 1242 1995 77 98
222. H.C. Rossbach L. Krizanac-Bengez E.B. Santos An antibody to CD44 enhances hematopoiesis in long-term marrow cultures Exp Hematol 24 1996 221 227
223. J.D. Rowley A new consistent chromosome abnormality in chronic myelogenous leukemia Nature 243 1973 209 291
224. V. Roy C.M. Verfaillie Adult marrow, cord blood and fetal liver progenitors differ in their adhesive properties and expression of cell adhesion molecules Blood 88 1996 2133a
225. F. Ruscetti L. Varesio A. Ochoa J. Ortaldo Pleiotropic effects of transforming growth factor–beta on cells of the immune system Ann NY Acad Sci 685 1993 488 500
226. N. Sakai Y. Ogiso H. Fujita Induction of apoptosis by a dominant negative H-RAS mutant (116Y) in K562 cells Exp Cell Res 215 1994 131
227. R. Salgia B. Brunkhorst E. Pisick Increased tyrosine phosphorylation of focal adhesion proteins in myeloid cell lines expressing p210BCR-ABL Oncogene 11 1995 1149
228. R. Salgia J.L. Li S.H. Lo Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210BCR-ABL J Biol Chem 270 1995 5039
229. R. Salgia J.R. Li E. Curry Transformation of hematopoietic cells by BCR-ABL is associated with enhanced motility Blood 88 1996 2684a
230. R. Salgia M. Sattler E. Pisick p210BCR/ABL induces formation of complexes containing focal adhesion proteins and the protooncogene product p120c-Cbl Exp Hematol 24 1996 31
231. I. Sanchez-Garcia G. Grutz Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2 Proc Natl Acad Sci USA 92 1995 5287
232. M. Sattler R. Salgia K. Okuda The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3′ kinase pathway Oncogene 12 1996 839
233. C.L. Sawyers W. Callahan O.N. Witte Dominant negative MYC blocks transformation by ABL oncogenes Cell 70 1992 901
234. C.L. Sawyers J. McLaughlin O.N. Witte Genetic requirement for RAS in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene J Exp Med 181 1995 307
235. C.L. Sawyers Molecular consequences of the BCR-ABL translocation in chronic myelogenous leukemia Leuk Lymphoma 11 suppl 2 1993 101 103
236. T.M. Saxton van Oostveen I. D. Bowtell B cell antigen receptor cross-linking induces phosphorylation of the p21ras oncoprotein activators SHC and mSOS1 as well as assembly of complexes containing SHC, GRB-2, mSOS1, and a 145-kDa tyrosine-phosphorylated protein J Immunol 153 1994 623
237. M.D. Schaller J.T. Parsons Focal adhesion kinase and associated proteins Curr Opin Cell Biol 6 1994 705 710
238. M.D. Schaller J.T. Parsons pp125FAK-dependent tyrosine phosphorylation of paxillin creates a high-affinity binding site for Crk Mol Cell Biol 15 1995 2635
239. C. Schindler Darnell J.E. Jr Transcriptional responses to polypeptide ligands: The JAK-STAT pathway Annu Rev Biochem 64 1995 621
240. D.D. Schlaepfer S.K. Hanks T. Hunter Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase Nature 372 1994 786
241. M.A. Schwartz M.D. Schaller M.H. Ginsberg Biol integrins: Emerging paradigms of signal transduction Annu Rev Cell Dev 11 1995 549 599
242. C. Selleri J.P. Maciejewski T. Sato N.S. Young Interferon-gamma constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition Blood 87 1996 4149 4157
243. C. Selleri T. Sato S. Anderson Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death J Cell Physiol 165 1995 538 546
244. R. Shofield The relationship between the spleen colony-forming cell and the hematopoietic stem cell: A hypothesis Blood Cells 4 1978 7 25
245. K. Shuai J. Halpern ten Hoeve J. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia Oncogene 13 1996 247
246. M. Siczkowski D. Clarke M.Y. Gordon Binding of primitive hematopoietic progenitor cells to marrow stromal cells involves heparan sulfate Blood 80 1992 912 919
247. T. Siitonen E.R. Savolainen P. Koistinen Expression of the c-kit proto-oncogene in myeloproliferative disorders and myelodysplastic syndromes Leukemia 8 1994 631 637
248. P.J. Simmons B. Masinovsky B.M. Longenecker Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells Blood 80 1992 388
249. C. Sirard T. Lapidot J. Vormoor Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis Blood 87 1996 1539
250. C. Sirard P. Laneuville J.E. Dick Expression of bcr-abl abrogates factor-dependent growth of human hematopoietic M07E cells by an autocrine mechanism Blood 83 1994 1575 1585
251. E. Sitnicka F.W. Ruscetti G.V. Priestley Transforming growth factor beta 1 directly and reversibly inhibits the initial cell divisions of long-term repopulating hematopoietic stem cells Blood 88 1996 82 88
252. T. Skorski M. Nieborowska-Skorska P. Wlodarski An intact SH3 domain is required for BCR/ABL leukemogenisis: Role in adhesion, invasion and homing Blood 88 1996 795a
253. T. Skorski P. Kanakaraj M. Nieborowska-Skorska Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome–positive cells Blood 86 1995 726
254. T.F.C.M. Smetsers T. Skorski van de Locht L.T.F. Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome–positive cell line BV173 Leukemia 8 1994 129
255. G.J. Spangrude D.M. Brooks D.B. Tumas Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: In vivo expansion of stem cell phenotype but not function Blood 85 1995 1006 1016
256. E.F. Srour E.D. Zanjani K. Cornetta Persistence of human multilineage, self-renewing lymphohematopoietic stem cells in chimeric sheep Blood 82 1993 3333 3342
257. A. Strife B. Clarkson Biology of chronic myelogenous leukemia: Is discordant maturation the primary defect? Semin Hematol 25 1988 1 19
258. A. Strife C. Lambek D. Wisniewski Proliferative potential of subpopulations of granulocyte-macrophage progenitor cells in normal subjects and chronic myelogenous leukemia patients Blood 62 1983 389 397
259. A. Strife C. Lambek D. Wisniewski Discordant maturation as the primary biological defect in chronic myelogenous leukemia Cancer Res 48 1988 1035 1041
260. A. Strife A. Perez C. Lambek Differences in the composition and in the efficiency of red cell production of normal and CML erythroid progenitor populations are highlighted by response to human c-kit ligand Leuk Res 17 1993 799 807
261. H.J. Sutherland C.J. Eaves A.C. Eaves Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro Blood 74 1989 1563 1570
262. H.J. Sutherland C.J. Eaves P.M. Lansdorp Differential regulation of primitive human hematopoietic cells in long-term cultures maintained on genetically engineered murine stromal cells Blood 78 1991 666 672
263. H.J. Sutherland D.E. Hogge D. Cook C.J. Eaves Alternative mechanisms with and without steel factor support primitive human hematopoiesis Blood 81 1993 1465 1470
264. H.J. Sutherland P.M. Lansdorp D.H. Henkelman Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers Proc Natl Acad Sci USA 87 1990 3584 3588
265. M. Takahashi A. Keating J.W. Singer A functional defect in irradiated adherent layers from chronic myelogenous leukemia long-term marrow cultures Exp Hematol 13 1985 926 931
266. H. Takahira H. Ideguchi J. Hirata Appearance of chromosomally normal hemopoiesis during busulfan-induced remission in a case of Ph1 positive chronic myelogenous leukemia Rinsho Ketsueki 30 1989 251 255
267. M. Talpaz Z. Estrov H. Kantarjian Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual colonies J Clin Invest 94 1994 1383 1389
268. M. Talpaz H. Kantarjian R. Kurzrock Interferon-alpha produces sustained cytogenetic response in chronic myelogenous leukemia. Philadelphia chromosome–positive patients Ann Intern Med 114 1991 532 538
269. T. Tauchi H.S. Boswell D. Leibowitz Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway J Exp Med 179 1994 167
270. T. Tauchi H.E. Broxmeyer BCR/ABL signal transduction Int J Hematol 61 1995 105 112
271. T.F. Tedder D.A. Steeber A. Chen P. Engel The selectins: Vascular adhesion molecules FASEB J 9 1995 866 873
272. hi stem cells to bone marrow stroma J Clin Invest 90 1992 358 367
273. K.K. Teng H. Lander J.E. Fajardo v-Crk modulation of growth factor-induced PC12 cell differentiation involves the Src homology 2 domain of v-Crk and sustained activation of the Ras/mitogen-activated protein kinase pathway J Biol Chem 270 1995 20677 20685
274. L.W. Terstappen S. Huang M. Safford Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38− progenitor cells Blood 77 1991 1218 1227
275. R. Tjian T. Maniatis Transcriptional activation: A complex puzzle with few easy pieces Cell 77 1994 5 8
276. M. Tubiana P. Carde E. Frindel Ways of minimising hematopoietic damage induced by radiation and cytostatic drugs—the possible role of inhibitors Radiother Oncol 29 1993 1 17
277. C. Udomsakdi C.J. Eaves H.J. Sutherland P.M. Lansdorp Separation of functionally distinct subpopulations of primitive human hematopoietic cells using rhodamine-123 Exp Hematol 19 1991 338 342
278. C. Udomsakdi C.J. Eaves B. Swolin Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level Proc Natl Acad Sci USA 89 1992 6192 6196
279. G. Upadhyaya S.C. Guba S.A. Sih Interferon-alpha restores the deficient expression of the cytoadhesion molecule lymphocyte function antigen-3 by chronic myelogenous leukemia progenitor cells J Clin Invest 88 1991 2131 2136
280. Van Den Berg D. M. Weesman L. Murray Leukemic burden in subpopulations of mobilized peripheral blood of α-interferon-resistant or -intolerant patients with chronic myeloid leukemia Blood 87 1996 4348
281. Van Etten R.A. P.K. Jackson D. Baltimore The COOH-terminus of the c-abl tyrosine kinase contains distinct F-actin and G-actin binding domains with bundling activity J Cell Biol 124 1994 325
282. Van Etten R.A. P.K. Jackson D. Baltimore The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization Cell 58 1989 669 678
283. C.M. Verfaillie Direct contact between progenitors and stroma is not required for human in vitro hematopoiesis Blood 79 1992 2821 2826
284. C.M. Verfaillie P. Catanzarro Development of a novel single LTC-IC proliferation assay that can determine the fate of LTC-IC over time Leukemia 10 1996 498 504
285. C.M. Verfaillie J.S. Miller CD34+/CD33− cells reslected from MIP−1a+IL3 supplemented “stroma-noncontact” cultures are highly enriched for LTBMC-IC Blood 84 1994 1442 1450
286. C. Verfaillie K. Blakolmer P. McGlave Purified primitive hematopoietic progenitor cells with long-term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma J Exp Med 172 1990 509 520
287. C.M. Verfaillie A. Benis G. Iida Adhesion of committed human hematopoietic progenitors to synthetic peptides in the C-terminal heparin-binding domain of fibronectin: Cooperation between the integrin α4β1 and the CD44 adhesion receptor Blood 84 1994 1802 1812
288. C.M. Verfaillie R. Bhatia W. Miller Benign primitive progenitors can be selected on the basis of the CD34+/HLA-DR- phenotype in early chronic phase but not advanced phase CML Blood 87 1996 4770 4779
289. C.M. Verfaillie J.B. McCarthy P.B. McGlave Differentiation of primitive human multipotent hematopoietic progenitors into single lineage clonogenic progenitors is accompanied by alterations in their interaction with fibronectin J Exp Med 174 1991 693 703
290. C.M. Verfaillie J.B. McCarthy P.B. McGlave Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia: Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV J Clin Invest 90 1992 1232 1239
291. C.M. Verfaillie W.J. Mille K. Boyland P.B. McGlave Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression Blood 79 1992 1003 1011
292. J.W. Voncken van Schaick H. V. Kaartinen Increased neutrophil respiratory burst in bcr-null mutants Cell 80 1995 719
293. J. Vormoor T. Lapidot F. Pflumio Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice Blood 83 1994 2489 2497
294. R.S. Weinberg A. Worsley H.S. Gilbert Comparison of erythroid progenitor cell growth in vitro in polycythemia vera and chronic myelogenous leukemia: Only polycythemia vera has endogenous colonies Leuk Res 13 1989 331 338
295. A. Weisz S. Kirchhoff B.Z. Levi IFN consensus sequence binding protein (ICSBP) is a conditional repressor of IFN inducible promoters International Immunology 6 1994 1125 1131
296. A. Weisz P. Marx R. Sharf Human interferon consensus sequence binding protein is a negative regulator of enhancer elements common to interferon-inducible genes J Biol Chem 267 1992 25589 25596
297. T.N. Wells C.A. Power M. Lusti-Narasimhan Selectivity and antagonism of chemokine receptors J Leuk Biol 59 1996 53 60
298. M. Wetzler H. Kantarjian R. Kurzrock M. Talpaz Interferon-alpha therapy for chronic myelogenous leukemia Am J Med 9 1995 402 411
299. M. Wetzler M. Talpaz D.G. Lowe Constitutive expression of leukemia inhibitory factor RNA by human bone marrow stromal cells and modulation by IL-1, TNF-α and TGF-β Exp Hematol 19 1991 347 352
300. M. Wetzler M. Talpaz Van Etten R.A. Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation J Clin Invest 92 1993 1925
301. D.A. Williams M. Rios C. Stephens Fibronectin and VLA-4 in haematopoietic stem cell–microenvironment interactions Nature 352 1991 438
302. D. Wisniewski A. Strife E. Berman B. Clarkson c-kit ligand stimulates tyrosine phosphorylation of a similar pattern of phosphotyrosyl proteins in primary primitive normal hematopoietic progenitors that are constitutively phosphorylated in comparable primitive progenitors in chronic phase chronic myelogenous leukemia Leukemia 10 1996 229 237
303. D. Wisniewski A. Strife D. Wojciechowicz A 62-kilodalton tyrosine phosphoprotein constitutively present in primary chronic phase chronic myelogenous leukemia enriched lineage negative blast populations Leukemia 8 1994 688 693
304. A.W. Wognum G. Krystal C.J. Eaves Increased erythropoietin-receptor expression on CD34-positive bone marrow cells from patients with chronic myeloid leukemia Blood 79 1992 642 649
305. H. Yaku T. Sasaki Y. Takai The Dbl oncogene product as a GDP/GTP exchange protein for the Rho family: Its properties in comparison with those of Smg GDS Biochem Biophys Res Commun 198 1994 811
306. T. Yamanashi D. Baltimore Identification of the Abl- and rasGAP-associated 62kDa protein as a socking protein, Dok Cell 88 1997 205 211
307. R. Yao G.M. Cooper Growth factor–dependent survival of rodent fibroblasts requires phosphatidylinositol 3-kinase but is independent of pp70S6K activity Oncogene 13 1996 343
308. R. Yao G.M. Cooper Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor Science 267 1995 2003
309. A.D. Yurochko D.Y. Liu D. Eierman S. Haskill Integrins as a primary signal transduction molecule regulating monocyte immediate-early gene induction Proc Natl Acad Sci USA 89 1992 9034 9038
310. 4 remain “homeless” and persist in circulation Blood 84 1994 1962a
311. F.C. Zeigler B.D. Bennett C.T. Jordan Cellular and molecular characterization of the role of the flk-2/flt-3 receptor tyrosine kinase in hematopoietic stem cells Blood 84 1993 2422 2430
312. B.R. Zetter Adhesion molecules in tumor metastasis Semin Cancer Biol 4 1993 219 229
313. X. Zhu M. Ohtsubo R.M. Böhmer Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein J Cell Biol 133 1996 391 403
314. S.H. Zigmond Signal transduction and actin filament organization Curr Opin Cell Biol 8 1996 66 73
315. J.M. Zijlmans J.W. Visser K. Kleiverda Modification of rhodamine staining allows identification of hematopoietic stem cells with preferential short-term or long-term bone marrow-repopulating ability Proc Natl Acad Sci USA 92 1995 8901 8905